Abbott donates 10,000 more FreeStyle Libre sensors

By Editor
28th January 2021
Audits, Technology

Healthcare professionals are being asked to submit data about how newly donated sensors for the FreeStyle Libre are being used for a future audit.

In July, Abbott donated up to 6,500 FreeStyle Libre sensors to hospitals across the UK to help staff better care for people with diabetes who are admitted during the COVID-19 pandemic.

Now, the company has agreed to send a further 10,000 sensors in response to a request from ABCD/DTN (Diabetes Technology Network.

DTN’s Co-Chair Professor Pratik Choudhary said: “With over 30,000 people admitted to hospital with COVID-19, and up to a third of them with diabetes, we know you are working flat out.

“With the use of steroids in many patients, the need for glucose monitoring to support care in hospital and support safe discharge is even greater than it was in the first wave.”

The donation is expected to help facilitate safe and rapid discharge of insulin treated people from hospital, allowing remote monitoring of glucose values post discharge in a scenario where there has been rapid changes in insulin doses.

Two sensors will be made available per person so they can be followed up in a “touch-free” manner, minimising contact between health care teams and people.

Trusts can apply to Abbott for the donation, and then DTN-UK will co-ordinate the use of these sensors for the purposes of the audit with the Trusts.

Professor Choudhary said: “We are aware of the demands of data collection at this time, so have kept this form as short as possible. It is important to feedback the degree of uptake from the donation and how sensors were used. ABCD-DTN may make contact with you for any other relevant information at a later date so please store the form locally until then.

“A number of clinicians have approached us with ideas for audit/research around this project, and we urge you to get in touch with ABCD / DTN through We shall try to connect those who are interested as a working group. ”

In the meantime ABCD/DTN has suggested process for issuing a FreeStyle Libre sensor:

  • Identify appropriate person
  • Fill in the excel form with details of indication and hospital number, to allow future audit.
  • The patient would have a sensor applied by a diabetes HCP, in the hospital, and be set up with FreeStyle LibreLink and LibreView prior to discharge.
  •  You may want to provide appropriate training on SMBG also at this time, if the patient is unlikely to meet local guidelines for on-going funding of FreeStyle Libre (alternatively this can be done at follow up with primary care, community or secondary care teams)
  • The patient should be discharged with an additional sensor.
  • The patient should be provided with a quick reference guide: ‘Your Guide to the FreeStyle Libre System’
  • If appropriate (eg Type 1 diabetes) provide a link to the DTN Flash glucose education page.
  • An early follow up call should be scheduled with the patient post discharge
  • At the end of the 4-week period (2 sensors) a decision to continue/discontinue local prescription of Libre sensors will depend on local guidelines. Patients who do not meet local guidelines for ongoing prescription of FreeStyle Libre will need to be transitioned to SMBG where appropriate.

They have also outlined an ordering process: 

  • The sensors will be available in increments of 48 or 96, so would cover 24 or 48 patients for one month’s use
  • This will be on a first come- first served basis, a second request for further stock is permitted, subject to equity and availability.
  • The Trust needs to make an individual charitable request to Abbott, using the recommended template provided by ABCD DTN which can be downloaded now.
  • E-mail Abbott directly on:, send signed charitable request form including a diabetes team contact name and delivery point/ department to process the order which will be shipped on a next day delivery service
  • You will be required to confirm delivery receipt with Abbott on

Comments (0)

Register an account or login to comment